Aligos Therapeutics (ALGS) Q4 2023 Earnings

12MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.53
-0.43
-0.32
-0.22

Details

Expected EPS
-0.27
Actual EPS
-0.22
Surprise EPS
0.05
Surprise Percent
+18.52%

Description

Aligos Therapeutics (ALGS) has reported earnings of -0.22 per share for Q4 2023.

0 Comments

Share your thoughts